Michael D. West - Mar 11, 2022 Form 4 Insider Report for AgeX Therapeutics, Inc. (AGE)

Role
Chief Executive Officer, Director
Signature
/s/Michael D. West
Stock symbol
AGE
Transactions as of
Mar 11, 2022
Transactions value $
-$887
Form type
4
Date filed
3/15/2022, 08:14 PM
Previous filing
Dec 14, 2021
Next filing
Jun 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGE Common Stock, $0.0001 par value Options Exercise $0 +3.13K +8.1% $0.00 41.7K Mar 11, 2022 Direct
transaction AGE Common Stock, $0.0001 par value Tax liability -$887 -1.28K -3.07% $0.69 40.4K Mar 11, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Restricted Stock Units Options Exercise $0 -3.13K -20% $0.00 12.5K Mar 11, 2022 Common Stock 3.13K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4.
F2 Restricted Stock Units vested on March 11, 2022.